Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
North America dominated the global oral solid dosage pharmaceutical formulation market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

Market Analysis and Insights: Global Oral Solid Dosage Pharmaceutical Formulation Market
The global Oral Solid Dosage Pharmaceutical Formulation market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Solid Dosage Pharmaceutical Formulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Solid Dosage Pharmaceutical Formulation market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Solid Dosage Pharmaceutical Formulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Solid Dosage Pharmaceutical Formulation market.

Global Oral Solid Dosage Pharmaceutical Formulation Scope and Market Size
Oral Solid Dosage Pharmaceutical Formulation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Solid Dosage Pharmaceutical Formulation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immediate Release
Extended Release
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim